About this article Cite this article Wirth, T., Faber, J., Depienne, C
2017;39(8S2):S111
The SELECT trial specifically showed that semaglutide 2.4 mg reduced the risk of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke by 20% compared to placebo in people with pre-existing cardiovascular disease and overweight or obesity
If you are working through this transition, that conversation will give you helpful context for why supporting the gut is non-negotiable in any midlife MCAS plan
Peptides help restore the body's own healing pathways, making them ideal for clients experiencing chronic stress, gut dysfunction, hormone imbalance, or metabolic resistance
More active satellite cells mean better muscle repair and maintenance capacity